Hypothesis: hypothalamic dysfunction and lipoatrophic diabetes.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines; D002395:Catecholamines / Q000037:antagonists & inhibitors; D003346:Corticotropin-Releasing Hormone / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D004298:Dopamine / Q000096:biosynthesis / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000097:blood / Q000378:metabolism; D005246:Feedback; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000503:physiopathology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D007986:Luteinizing Hormone / Q000097:blood; D008543:Melanins / Q000378:metabolism; D009074:Melanocyte-Stimulating Hormones / Q000097:blood; D009490:Neurosecretory Systems / Q000187:drug effects; D009638:Norepinephrine / Q000096:biosynthesis / Q000494:pharmacology; D010858:Pigmentation; D010908:Pituitary Hormones, Anterior / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism / Q000494:pharmacology
D001679:Biogenic Amines; D002395:Catecholamines; D007004:Hypoglycemic Agents; D008543:Melanins; D010908:Pituitary Hormones, Anterior; D014443:Tyrosine; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009074:Melanocyte-Stimulating Hormones; D003346:Corticotropin-Releasing Hormone; D004299:Dopamine beta-Hydroxylase; D000262:Adenylyl Cyclases; D004298:Dopamine; D009638:Norepinephrine